EPIMAG: International Cross-Sectional Epidemiological Psoriasis Study in the Maghreb

Dermatology

Volumn 231, Issue 2, 2015, Pages 134-144

  Ammar Khodja, Aomar ^a   Benkaidali, Ismail ^a   Bouadjar, Bakar ^a   Serradj, Amina ^b   Titi, Abdelhamid ^c   Benchikhi, Hakima ^d   Amal, Said ^e   Hassam, Badreddine ^f   Sekkat, Abdelhak ^g   Mernissi, Fatima Zahra ^h   Mokhtar, Inçaf ⁱ   Dahoui, Raouf ^j   Denguezli, Mohamed ^k   Doss, Nejib ^j   Turki, Hamida ^l  

^a CHU Mustapha   (Algeria)

^b UNIVERSITY OF ORAN   (Algeria)

^c BADJI MOKHTAR UNIVERSITY   (Algeria)

^d IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^e CHU Mohamed   (Morocco)

^f IBN SINA HOSPITAL   (Morocco)

^g Cheikh Zaid International Hospital   (Morocco)

^h HASSAN II UNIVERSITY HOSPITAL   (Morocco)

ⁱ HABIB THAMEUR HOSPITAL   (Tunisia)

^j MILITARY HOSPITAL OF TUNIS   (Tunisia)

^k FARHAT HACHED HOSPITAL   (Tunisia)

^l HEDI CHAKER HOSPITAL   (Tunisia)

more..

Author keywords

Characterization; Epidemiology; Frequency; Prevalence; Psoriasis; Screening

Indexed keywords

ADULT; ALGERIA; ARTICLE; CROSS-SECTIONAL STUDY; FAMILY HISTORY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOROCCO; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PSORIASIS VULGARIS; QUALITY OF LIFE; SCREENING; SYSTEMIC THERAPY; TOPICAL TREATMENT; TUNISIA; ADOLESCENT; AGED; CLINICAL TRIAL; COMPLICATION; GENETICS; MEDICAL LEAVE; MENTAL STRESS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; SEASON; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGERIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOROCCO; PRURITUS; PSORIASIS; QUALITY OF LIFE; SEASONS; SEVERITY OF ILLNESS INDEX; SICK LEAVE; STRESS, PSYCHOLOGICAL; TUNISIA; YOUNG ADULT;

EID: 84939575435     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000382123     Document Type: Article

References (42)

1. Langley RG, Krueger GG, Griffiths CE. Psoriasis. epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64(suppl 2). ii18-ii23, discussion ii4-ii5
2. Schon MP, Boehncke WH, Brocker EB. Psoriasis. clinical manifestations, pathogenesis and therapeutic perspectives. Discov Med 2005; 5. 253-258
3. Ammar M, Zaraa I, Bouchleka Souissi C, Dhaoui A, Doss N, Ben Osman A, et al. Familial psoriasis. descriptive report of 9 families (in French). Tunis Med 2009; 87. 750-754
4. Dereure O, Guilhou JJ. Epidemiology and genetics of psoriasis (in French). Ann Dermatol Venereol 2003; 130. 829-836
5. Guinot C, Latreille J, Perrussel M, Doss N, Dubertret L. Psoriasis. characterization of six different clinical phenotypes. Exp Dermatol 2009; 18. 712-719
6. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41. 401-407
7. National Psoriasis Foundation 2008 survey panel snapshot. http://www.psoriasis.org/ document.doc?id=193 (accessed January 23, 2013)
8. Evers AW, Lu Y, Duller P, van der Valk PG, Kraaimaat FW, van de Kerkhof PC. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol 2005; 152. 1275-1281
9. Boudaya S, Turki H, Marrakchi S, Meziou TJ, Bouassida S, Zahaf A. Le psoriasis de l'enfant. etude epidemiologique de 196 observations. Nouv Dermatol 2004; 23. 13-16
10. Daoud L, Dhaoui MR, Youssef S, Jaber K, Doss N. Management of severe psoriasis. about 50 cases (in French). Tunis Med 2007; 85. 849-856
11. Jalal O, Houass S, Laissaoui K, Hocar O, Charioui S, Amal S. Severe psoriasis. 160 cases (in French). Ann Dermatol Venereol 2005; 132. 126-128
12. Skali S, Berrada R, Benchikhi H, Lakhdar H. Profil epidemiologique du psoriasis au service de dermatologie de Casablanca. Etude de 3,021 cas. Nouv Dermatol 2009; 28. 427-430
13. Zaara SY, Mrabet A, Jaber K, Ketaeri I, Ben Mna A, Amri A, et al. Epidemiology of severe non-infectious skin diseases of foot among soldiers. a study of 128 inpatient cases. Rev Tunisienne Sante Milit 2010; 12. 184-188
14. Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34:J314-J321
15. Benchikhi H, Amal S, Ammar-Khodja A, Benkaidali I, Bouadjar B, Dhaoui M, et al. Etude PSOMAG. prevalence des cas de psoriasis au Maghreb (abstract P097). Ann Dermatol Venereol 2012; 139:B162-B163
16. Guideline on clinical investigation of medicinal products indicated for the treatment of psoriasis. EMEA/CHMP/EWP/2454/02. London, November 18, 2004
17. Christophers E. Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26. 314-320
18. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom. a population-based study. Arch Dermatol 2005; 141. 1537-1541
19. World Health Organization. Country cooperation strategy at a glance. Tunisia. http:// www.who.int/countryfocus/cooperation- strategy/ccsbrief-tun-en.pdf. 2006 (accessed January 23, 2013)
20. Semlali H. The global health workforce alliance. Positive practice environments in Morocco. http://www.who.int/workforcealliance/ knowledge/PPE-Morocco-CaseStudy.pdf. 2010 (accessed January 23, 2013)
21. Aounallah-Skhiri H, Lazaar-Ben Gobrane H, Hsairi M, Achour N, Zouari B, Nacef T. Medical demography in Tunisia. current situation and perspectives (in French). Tunis Med 2012; 90. 166-171
22. De la Brassinne M, Failla V, Nikkels A. Psoriasis. state of the art 2013. Acta Clin Belg 2013; 68. 427-432
23. Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis. results from an Italian case-control study. J Invest Dermatol 2005; 125. 61-67
24. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women. Nurses' Health Study II. Arch Intern Med 2007; 167. 1670-1675
25. Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity. a systematic review and meta-analysis of observational studies. Nutr Diabetes 2012; 2:e54
26. Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus. a systematic review and meta-analysis. JAMA Dermatol 2013; 149. 84-91
27. Brauchli YB, Jick SS, Meier CR. Psoriasis and the risk of incident diabetes mellitus. a population-based study. Br J Dermatol 2008; 159. 1331-1337
28. Gelfand JM, Stern RS, Nijsten T, Feldman SR, Thomas J, Kist J, et al. The prevalence of psoriasis in African Americans. results from a population-based study. J Am Acad Dermatol 2005; 52. 23-26
29. Rigopoulos D, Gregoriou S, Katrinaki A, Korfitis C, Larios G, Stamou C, et al. Characteristics of psoriasis in Greece. an epidemiological study of a population in a sunny Mediterranean climate. Eur J Dermatol 2010; 20. 189-195
30. Valenzuela F, Silva P, Valdes MP, Papp K. Epidemiology and quality of life of patients with psoriasis in Chile. Actas Dermosifiliogr 2011; 102. 810-816
31. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9. 136-139
32. Fouere S, Adjadj L, Pawin H. How patients experience psoriasis. results from a European survey. J Eur Acad Dermatol Venereol 2005; 19(suppl 3):2-6
33. Vena GA, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S, et al. Incidence of psoriasis and association with comorbidities in Italy. a 5-year observational study from a national primary care database. Eur J Dermatol 2010; 20. 593-598
34. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica 1974; 148. 1-18
35. Seville RH. Psoriasis and stress. Br J Dermatol 1977; 97. 297-302
36. Fortune DG, Richards HL, Main CJ, Griffiths CE. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998; 39. 196-201
37. Bardazzi F, Balestri R, Baldi E, Antonucci A, De Tommaso S, Patrizi A. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy. Dermatol Ther 2010; 23(suppl 1):S14-S19
38. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults. results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60. 218-224
39. Garcia-Diez A, Foraster CF, Sebastian FV, Tudela LL, Llach XB, Fernandez GS. What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region. Dermatology 2008; 216. 137-151
40. Al-Mazeedi K, El-Shazly M, Al-Ajmi HS. Impact of psoriasis on quality of life in Kuwait. Int J Dermatol 2006; 45. 418-424
41. Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients. findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One 2012; 7:e52935
42. Pearce DJ, Singh S, Balkrishnan R, Kulkarni A, Fleischer AB, Feldman SR. The negative impact of psoriasis on the workplace. J Dermatolog Treat 2006; 17. 24-28